Abstract
Primary central nervous system post-transplant lymphoproliferative disease (CNS PTLD) is a serious complication after solid organ transplantation that has not received much attention so far. However, it could become a more frequent problem with the introduction of new biological agents.
Methods
We identified five cases with CNS PTLD in our center who were transplanted between 1986 and 2007, three men and two women, with a mean age of 55.9 years (range 42–74). Three patients had received only kidney transplant and two patients had received a kidney–pancreas transplant.
Results
The mean time from first symptoms until diagnosis was 3.5 months (2–6). One patient was diagnosed post-mortem in autopsy. The mean time from transplantation to onset of neurological symptoms was 73.8 months (31–144). The initial clinical manifestation was heterogeneous: all five cases showed headache, four cases presented with gait disturbance, one with dysarthria and two with a confusional state. Epstein–Barr virus (EBV) immunoglobulin (Ig)G serology was positive in four out of five cases; in situ hybridization for EBV in brain biopsy samples was positive in three cases, negative in one and not available in one. In four patients, EBV polymerase chain reaction (PCR) was positive in cerebrospinal fluid (CSF). After diagnosis, overall immunosuppressive load was lowered in all patients (n = 4). Three patients died at 8–104 weeks (mean 40 weeks) after diagnosis and one patient is still alive 20 months after diagnosis.
Conclusions
CNS PTLD is a complication difficult to diagnose, frequently diagnosed too late and often refractory to treatment. A more aggressive screening might be necessary in patients even with mild CNS symptoms.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Opelz G, Daniel V, Naujokat C, Döhler B (2009) Epidemiology of pretransplant EBV and CMV serostatus in relation to posttransplant non-Hodgkin lymphoma. Transplantation 88:962–967
Snanoudj R, Durrbach A, Leblond V et al (2003) Primary brain lymphomas after kidney transplantation: presentation and outcome. Transplantation 76:930–937
Green M, Webber S (2003) Posttransplantation lymphoproliferative disorders. Pediatr Clin North Am 50:471–1491
Ibrahim HA, Naresh KN (2012) Posttransplant lymphoproliferative disorders. Adv Hematol 2012: Article ID 230173. doi:10.1155/2012/230173
Dharnidharka VR, Tejani AH, et al (2002) Post-transplant lymphoproliferative disorder in the United States: young Caucasian males are at highest risk. Am J Transplant 2:993–998
Caillard S, Dharnidharka V, Agodoa L, Bohen E, Abbott K (2005) Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression. Transplantation 80:1233–1243
Daan D (2011) Posttransplant lymphoproliferative disorders following kidney transplantation. In: Ortiz J (ed) After the kidney transplant—the patients and their allograft. Rijeka. ISBN:978-953-307-807-6
Grinyó J et al (2010) An integrated safety profile analysis of belatacept in kidney transplant recipients. Transplantation 90:1521–1527
Arora S, Tangirala B, Osadchuk, et al (2012) Belatacept: a new biological agent for maintenance immunosuppression in kidney transplantation. Expert Opin Biol Ther 12:965–79
Batchelor T, Loeffler JS (2006) Primary CNS lymphoma. J Clin Oncol 24:1281–1288
Castellano-Sanchez AA, Li S, Qian J et al (2004) Primary central nervous system posttransplant lymphoproliferative disorders. Am J Clin Pathol 121:246–253
Cavaliere R, Petroni G, Lopes MB et al (2010) Primary central nervous system post-transplantation lymphoproliferative disorder: an International Primary Central Nervous System Lymphoma Collaborative Group Report. Cancer 116:863–870
Phan TG, O’Neill BP, Kurtin PJ (2000) Posttransplant primary CNS lymphoma. Neuro Oncol 2:229–238
Evens AM, Choquet S et al (2013) Primary CNS Posttransplant lymphoproliferative disease (PTLD): an International Report of 84 Cases in the Modern Era. Am J Transplant 13(6):1512–1522. doi:10.1111/ajt.12211
Gutierrez-Dalmau A, Campistol JM (2007) Immunosuppressive therapy and malignancy in organ transplant recipients. Drugs 67:1167–1198
Chou AP, Lalezari S, Fong BM et al (2011) Post-transplantation primary central nervous system lymphoma: a case report and review of the literature. Surg Neurol Int 2:130
Alderson L, Fetell MR, Sisti M et al (1996) Sentinel lesions of primary. J Neurol Neurosurg Psychiatry 60:102–105
Kuhlmann T, Schroter A, Dechent P et al (2001) Diagnosis of a multifocal B cell lymphoma with preceding demyelinating central nervous system lesions by single voxel proton MR spectroscopy. J Neurol Neurosurg Psychiatry 70:259–262
Arita H, Izumoto S, Kinoshita M et al (2010) Posttransplant lymphoproliferative disorders of the central nervous system after kidney transplantation: single center experience over 40 years. Two case reports. Neurol Med Chir 50:1079–1083
Keswani A, Bigio E, Grimm S (2012) Lymphomatosis cerebri presenting with orthostatic hypotension, anorexia, and paraparesis. J Neuro Oncol 109:581–586
Cinque P, Brytting M, Vago L et al (1993) Epstein–Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system. Lancet 342:398–401
Bossolasco S, Cinque P, MPonzoni M, et al. Epstein–Barr virus DNA load in cerebrospinal fluid and plasma of patients with AIDS-related lymphoma. J Neurovirol. 2002; 8, 432–438
Higuchi M, Hata Takenori, Fururya S, et al (2005) Epstein–Barr virus-related primary central nervous system lymphoma after cadaveric renal transplantation improved by treatment with high-dose methotrexate followed by irradiation. Nephrology 10:321–4
Evens AM, David KA, Helenowski I et al (2010) Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern era. J Clin Oncol 28:1038–1046
Taylor AL, Marcus R, Bradley JA (2005) Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation. Crit Rev Oncol Hematol 56:155–167
Green M (2001) Management of Epstein–Barr virus-induced post-transplant lymphoproliferative disease in recipients of solid organ transplantation. Am J Transplant 1:103–108
Conflict of interest
Authors do not have any conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sola-Valls, N., Rodríguez C, N.Y., Arcal, C. et al. Primary brain lymphomas after kidney transplantation: an under-recognized problem?. J Nephrol 27, 95–102 (2014). https://doi.org/10.1007/s40620-013-0026-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40620-013-0026-z